Primer, kit and method for detecting Staphylococcus aureus

Through the detection method of Staphylococcus aureus based on LAMP technology, the primers of the target gene DUF1361 domain-containing protein and the hydroxynaphthol blue color developer were used to solve the problems of long detection cycle and insufficient sensitivity in the existing detection methods, and achieve rapid , accurate test results, suitable for the application of primary medical units.

CN114990237BInactive Publication Date: 2024-11-26CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111276905.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-10-29
Publication Date
2024-11-26
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing Staphylococcus aureus detection methods have problems with long detection cycles, insufficient sensitivity and specificity, especially traditional bacterial culture methods and immunology methods. The PCR method equipment is expensive and complex, which is not conducive to the promotion of primary medical units.

Method used

A detection method based on LAMP technology was designed, using the specific base sequence of the target gene DUF1361 domain-containing protein, and combining hydroxynaphthol blue color developer to achieve rapid and accurate visual detection, mediating isotherm through loop mediation Amplification technology performs an amplification reaction for 30 to 60 minutes at 60 to 65°C.

Benefits of technology

It realizes fast, accurate and high specific detection of Staphylococcus aureus, with a sensitivity of 8 copies/μL, and does not require expensive instruments and cumbersome electrophoretic analysis, and has good promotion and application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114990237B_ABST
    Figure CN114990237B_ABST
Patent Text Reader

Abstract

The present invention provides a method for detecting Staphylococcus aureus based on loop-mediated isothermal amplification technology, and provides detection primers and a kit. The method of the present invention uses primers capable of amplifying the target gene DUF1361domain-containing protein (GenBank accession number is CP038229.1) for amplification, and uses hydroxynaphthol blue color development to achieve rapid visual detection, with high specificity and sensitivity, accurate and reliable detection results, and has very good promotion and application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of microbial detection, and in particular relates to a primer, a kit and a method for detecting Staphylococcus aureus. Background Art

[0002] Staphylococcus aureus is a common human pathogen that can secrete a variety of virulence factors (enterotoxins, hemolytic toxins, leukocidins, plasma coagulase, etc.) and has strong pathogenicity. Staphylococcus aureus can cause a wide range of clinical infections, from local skin and soft tissue infections to life-threatening necrotizing pneumonia, sepsis, etc. At the same time, it is also the main cause of bone and joint, chest and lung, and hospital equipment-related infections. Therefore, the development of a reliable, rapid, and accurate diagnostic method for the detection of Staphylococcus aureus is an urgent clinical need.

[0003] Traditional methods for detecting Staphylococcus aureus mainly include: bacterial culture method, immunological method, and molecular diagnostic method. Bacterial culture method is a conventional method for clinical microbiological detection. It has the advantages of simple operation, simple equipment and relatively low cost. However, its detection cycle is too long, usually taking 2-5 days to get a diagnosis result. For this reason, many patients may miss the best treatment period. In addition, clinical empirical medication before the diagnosis result comes out may cause bacteria to develop drug resistance. Immunological methods are easily affected by antibody purity or quality, have more serious cross-reactions, and have many false positives. Molecular diagnostic methods have high sensitivity and specificity, and can complete detection in a short time. The PCR method can quickly and sensitively detect Staphylococcus aureus, but PCR detection requires expensive laboratory instruments, reagents and skilled operators, which is not conducive to promotion in primary medical units.

[0004] With the development of molecular biology and people's continuous improvement of traditional nucleic acid amplification technology, Notomi et al. reported a fast and convenient nucleic acid amplification method in 2000: loop-mediated isothermal amplification (LAMP). LAMP technology uses four primers to identify the target sequence, with high selectivity and good amplification specificity. It can amplify trace amounts of initial DNA copies to one million copies within one hour under isothermal conditions (around 65°C), and does not require pre-denaturation of the template. The reaction results can be detected by turbidity, electrophoresis, fluorescence and colorimetry. Compared with traditional technologies, LAMP technology has the advantages of short reaction time and simple operation, but its primer design is complex, and the stability and accuracy of the rapid detection process are still somewhat different from those of conventional PCR.

[0005] At present, researchers have established a method for detecting Staphylococcus aureus based on LAMP technology. For example, Zhang Xiaoyu et al. used the nuc gene (GenBank NO.DQ507379.1) of Staphylococcus aureus as the target gene, designed primers to construct a LAMP detection method for Staphylococcus aureus, with good specificity and a minimum detection line of 27 copies / μL, which is 100 times that of the PCR method (Zhang Xiaoyu, Wang Wenwen, Ma Chenjie, Wu Xiaoling, Deng Guangcun. Establishment and application of LAMP detection method for Staphylococcus aureus [J]. Journal of Agricultural Biotechnology, 2021, 29(09): 1845-1854.); Koide et al. constructed a LAMP detection method for Staphylococcus aureus based on mecA and spa genes as target genes, with a specificity of up to 100% and sensitivities of 69.2% and 52.9%, respectively (Koide Y, Maeda H, Yamabe K, et al. Rapid detection of mecA and spa by the loop-mediated isothermal amplification (LAMP) method. [J]. Letters in Applied Microbiology, 2010, 50 (4): 386-392.). It can be seen that the detection sensitivity and accuracy of the LAMP method constructed by the above-mentioned prior art still need to be further improved.

[0006] Therefore, further exploration is needed to establish a simpler, faster and more accurate method for detecting Staphylococcus aureus. Summary of the invention

[0007] The purpose of the present invention is to provide a method for detecting Staphylococcus aureus simply, quickly and accurately based on LAMP technology.

[0008] The invention provides a primer set for detecting Staphylococcus aureus, which is a primer set capable of amplifying a specific base sequence of a target gene; the target gene is DUF1361 domain-containing protein, with GenBank accession number CP038229.1, and the specific base sequence is the 704683-705300 base sequence of the target gene, as shown in SEQ ID NO.1.

[0009] Further, it includes the following primers:

[0010] External primer F3: the sequence is shown in SEQ ID NO.2;

[0011] External primer B3: the sequence is shown in SEQ ID NO.3;

[0012] Internal primer FIP: the sequence is shown in SEQ ID NO.4;

[0013] Internal primer BIP: The sequence is shown in SEQ ID NO.5.

[0014] The invention provides a kit for detecting Staphylococcus aureus, which comprises the above primer set.

[0015] Further, it includes the following components in parts by volume:

[0016] 10× buffer: 2.5 parts, 8.0 U / μL Bst 2.0 DNA polymerase: 1 part, 100 mM magnesium sulfate aqueous solution: 1.5 parts, 10 mM dNTP aqueous solution: 3 parts, 5 M betaine aqueous solution: 4 parts, 10 μM outer primer F3 aqueous solution: 0.5 parts, 10 μM outer primer B3 aqueous solution: 0.5 parts, 10 μM inner primer FIP aqueous solution: 4 parts, 10 μM inner primer BIP aqueous solution: 4 parts, water: 2 parts;

[0017] The 10× buffer contains 200 mM Tris-HCl (pH 8.8), 500 mM potassium chloride, 100 mM ammonium sulfate, 20 mM magnesium sulfate, and 1% v / v Tween-20.

[0018] Furthermore, the water is enzyme-free water.

[0019] Furthermore, the above kit also includes a color developer, which is hydroxynaphthol blue, SYBR TM Green I, ethidium bromide or calcein; preferably hydroxynaphthol blue.

[0020] Furthermore, the dosage of the above hydroxynaphthol blue is: 1 volume part of 3 mM hydroxynaphthol blue aqueous solution.

[0021] The present invention also provides a method for detecting Staphylococcus aureus, comprising the following steps:

[0022] (1) extracting genomic DNA of the sample to be tested;

[0023] (2) mixing the DNA extracted in step (1) with the components of the above-mentioned kit to form a reaction system;

[0024] (3) The reaction system obtained in step (2) is amplified at 60-65° C. for 30-60 minutes, and then the reaction is terminated by maintaining the temperature at 75-85° C. for 1-3 minutes.

[0025] (4) The amplification results are obtained by gel electrophoresis and / or visual observation.

[0026] Furthermore, if the above reaction system does not contain a color developer, step (4) uses gel electrophoresis to detect the amplification result.

[0027] Furthermore, if the reaction system contains a color developer, the amplification result is obtained by visual observation in step (4).

[0028] The beneficial effects of the present invention are as follows: the present invention uses a specific gene DUF1361domain-containing protein (GenBank accession number is CP038229.1 (704683-705300)) of Staphylococcus aureus as a target gene, designs primers and constructs a LAMP reaction system, adopts a hydroxynaphthol blue (HBN) color developer to reflect the amplification result and thus indicate the detection result, the amplification result can be interpreted by naked eyes, and visual detection can be achieved without expensive instruments and cumbersome electrophoresis analysis, and the detection is fast and accurate, with high specificity and sensitivity, and has good popularization and application value.

[0029] The enzyme-free water described in the present invention is nuclease-free water.

[0030] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.

[0031] The above contents of the present invention are further described in detail below through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 Optimize results for HNB dye concentration.

[0033] Figure 2 Results of specificity evaluation of the LAMP method: a: visual results; b: electrophoresis results.

[0034] Figure 3 The sensitivity evaluation results of the LAMP method: a: visual results; b: electrophoresis results.

[0035] Figure 4 Results of clinical diagnostic efficiency evaluation of the LAMP method: a: naked eye visualization result; b: electrophoresis result. DETAILED DESCRIPTION

[0036] The experimental methods used in the embodiments of the present invention are conventional methods unless otherwise specified, and the materials and reagents used in the embodiments are commercially available unless otherwise specified.

[0037] Some of the materials in each embodiment of the present invention are: Bst 2.0 DNA polymerase purchased from New England Biolabs; betaine (analytical grade), dNTP purchased from Sangon Biotech Co., Ltd.; HNB purchased from Aladdin Reagent Co., Ltd.; Vectors and Trans1-T1 chemically competent cells were purchased from Quanshijin Biotechnology Co., Ltd.; rapid plasmid extraction kit was purchased from Tiangen Biochemical Technology Co., Ltd.

[0038] Strains: 1 standard strain of Staphylococcus aureus (ATCC 25923), 14 standard strains of non-Staphylococcus aureus [Salmonella enterica (ATCC 14028), Serratia marcescens (CMCC B 41002), Enterobacter cloacae (CMCC B45301), Klebsiella pneumoniae (CMCC B 46117), Alcaligenes faecalis (ATCC 8750), Escherichia coli (ATCC 25922), Enterococcus faecalis (ATCC 29212), Staphylococcus epidermidis (ATCC 12228), Shigella flexneri (ATCC 12022), Shigella dysenteriae (CMCC B 51105), Pseudomonas aeruginosa (ATCC 27853), Vibrio parahaemolyticus (ATCC 17802), Vibrio alginolyticus (CICC 21664), Enterococcus faecium (ATCC 19434)]. Note: ATCC, American Type Culture Collection; CMCC, China Medical Bacteria Collection Center; CICC, China Industrial Microbiology Collection Center.

[0039] Example 1, kit of the present invention

[0040] The kit of the present invention includes the following components and dosages (25 μL system):

[0041] raw material Dosage 10× Buffer 2.5μL 8.0U / μL Bst 2.0 DNA polymerase 1.0μL <![CDATA[100mM MgSO4(Mg 2+ )]]> 1.5μL 10mM dNTP 3.0μL 5M Betaine 4.0μL 10μM F3 0.5μL 10μM B3 0.5μL 10 μM FIP 4.0μL 10 μM BiP 4.0μL 3mM HNB 1.0μL Enzyme-free water 2.0μL

[0042] *Wherein, 10X buffer consists of 200 mM Tris-HCl (pH 8.8@25°C), 500 mM KCl, 100 mM (NH4)2SO4, 20 mM MgSO4, 1% v / v Tween-20.

[0043] The amount of HNB used is variable and can be 0 μL, 0.50 μL, 0.75 μL, 1.00 μL, 1.25 μL, or 1.50 μL.

[0044] Example 2: Construction and detection method of LAMP detection system of the present invention

[0045] (1) Extract genomic DNA from the sample (strain) to be tested: prepare sample pretreatment solution: Solution A (125mM NaOH, 1mM EDTA, 0.1% Tween 20); Solution B (250mM HCl, 10mM Tris-HCl). If the original material is a liquid culture sample, take 1mL and centrifuge at 10,000rpm for 1min, remove the supernatant, and rinse twice with saline; if it is cultured on a solid culture medium, directly pick a single colony and rinse with saline; add sample pretreatment solution A to the bacterial sample obtained above, lyse at 65℃ for 10min, then add sample pretreatment solution B, centrifuge at 10,000rpm for 5min, and the supernatant obtained is the sample DNA template.

[0046] (2) Based on the kit of Example 1 as the amplification system, a LAMP reaction system was constructed:

[0047] A 25 μL reaction system was prepared in a 200 uLEP tube. The system contained (the following concentrations refer to the final concentrations in the reaction system): 1× buffer [20 mM Tris-HCl (pH 8.8 @ 25 °C), 50 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Tween-20], 0.32 U / μL Bst 2.0 DNA polymerase, 8.0 mM Mg 2+ (MgSO4 from 1× buffer at a final concentration of 2 mM was included 2+ , and additional Mg from MgSO4 to a final concentration of 6 mM 2+ ), 1.2 mM dNTP, 0.8 M betaine, 120 μM HNB, 0.2 μM F3 and B3, 1.6 μM FIP and BIP, 1.0 μL genomic DNA extracted in step (1) (the amount of genomic DNA can be varied), and enzyme-free water, and mix well.

[0048] The reaction system was kept at 64°C for 45 min and then kept at 80°C for 2 min to terminate the reaction.

[0049] A blank control was set up for each reaction (with enzyme-free water instead of the Staphylococcus aureus genome template). After the reaction, the amplification results were observed visually (positive results were sky blue, negative results were lavender) and the results were re-verified by electrophoresis.

[0050] The beneficial effects of the present invention are demonstrated by experimental examples below.

[0051] Experimental Example 1: Optimization of HNB dye concentration

[0052] Based on the LAMP detection system constructed in Example 2, HNB was set to 60, 90, 120, 150, 180 μM, 5 concentration gradients, from which the optimal concentration was screened for subsequent visualization detection.

[0053] The results are shown in the instruction manual Figure 1 As can be seen from the figure, when the HNB concentration is not less than 120 μM, the blue and purple colors are obvious and easy to distinguish, which is suitable for naked eye observation and judgment. Considering the dosage cost comprehensively, the final concentration of HNB of 120 μM is finally selected as the most preferred concentration.

[0054] Experimental Example 2: Methodological evaluation of the LAMP detection method of the present invention

[0055] 1. Experimental methods

[0056] (1) Evaluation of LAMP method specificity: The LAMP reaction system of Example 2 was used to evaluate the specificity of 15 standard bacteria (1 standard strain of Staphylococcus aureus (ATCC 25923), 14 standard strains of non-Staphylococcus aureus [Salmonella enterica (ATCC 14028), Serratia marcescens (CMCC B41002), Enterobacter cloacae (CMCC B 45301), Klebsiella pneumoniae (CMCC B 46117), Alcaligenes faecalis (ATCC 8750), Escherichia coli (ATCC 25922), Enterococcus faecalis (ATCC 29212), Staphylococcus epidermidis (ATCC 12228), Shigella flexneri (ATCC 12022), Shigella dysenteriae (CMCC B 51105), Pseudomonas aeruginosa (ATCC 27853), Vibrio parahaemolyticus (ATCC 17802), Vibrio alginolyticus (CMCC B 51105) 21664) and Enterococcus faecium (ATCC 19434). According to the color reaction results, a positive reaction was shown as sky blue, and a negative reaction was shown as lavender.

[0057] (2) Sensitivity evaluation of LAMP method:

[0058] Construction of positive plasmid: Using the genome of Staphylococcus aureus as template, PCR amplification was performed using the above primers F3 and B3, and the bands were recovered and cloned into The vector was then transferred into Trans1-T1 chemical competent cells. The cells were enriched and cultured in LB liquid medium containing ampicillin. The plasmid was extracted using a rapid plasmid extraction kit and the concentration was detected using ND5000 (BioTek). The copy number conversion was performed using the following website (https: / / www.thermofisher.cn / cn / zh / home / brands / thermo-scientific / molecular-biology / molecular-biology-learning-center / molecular-biology-resource-library / thermo-scientific-web-tools.html?adobe_mc=MCMID%7C26772036826659455471782103365893074583%7CMCAID%3D2EE3C392052A142D-600001056000F22B%7CMCORGID%3D5B135A0C5370E6B40A490D44%40AdobeOrg%7CTS=1614293705).

[0059] The positive plasmid was diluted 10 times to 8 × 10 8 -8×10 0 copies / μL and used for LAMP sensitivity assessment.

[0060] 2. Experimental results

[0061] (1) Specificity of LAMP method: The standard strain of Staphylococcus aureus (ATCC 25923) was positive, and the other 14 strains of non-Staphylococcus aureus [Salmonella enterica (ATCC 14028), Serratia marcescens (CMCC B 41002), Enterobacter cloacae (CMCC B 45301), Klebsiella pneumoniae (CMCC B 46117), Alcaligenes faecalis (ATCC 8750), Escherichia coli (ATCC 25922), Enterococcus faecalis (ATCC 29212), Staphylococcus epidermidis (ATCC 12228), Shigella flexneri (ATCC12022), Shigella dysenteriae (CMCC B 51105), Pseudomonas aeruginosa (ATCC 27853), Vibrio parahaemolyticus (ATCC17802), Vibrio alginolyticus (CICC 21664), Enterococcus faecium (ATCC 19434)] The test results were all negative. The results are shown in the appendix of the instruction manual. Figure 2 , indicating that this method has good specificity.

[0062] (2) Sensitivity of LAMP method: After the constructed positive plasmid was diluted 10 times, the final concentration in each tube was 8×10 8 , 8×10 7 , 8×10 6 , 8×10 5 , 8×10 4 , 8×10 3 , 8×10 2 , 8×10 1 , 8×10 0 Copies / μL, amplification results are attached Figure 3 , indicating that the sensitivity of this method is 8 copies / μL.

[0063] Experimental Example 3: Evaluation of the clinical diagnostic efficiency of the LAMP detection method of the present invention for detecting Staphylococcus aureus

[0064] (1) Strains: From January to May 2021, a total of 369 bacterial strains (including 220 Staphylococcus aureus and 169 non-Staphylococcus aureus) were isolated from Sichuan Provincial Hospital of Traditional Chinese Medicine and Chengdu Fifth People's Hospital. These strains were identified to the species level using the VITEK 2 microbial automatic identification instrument (Mérieux, France). All strains were inoculated in tryptic soy broth (TSB) liquid culture medium and cultured at 37°C with shaking at 200 rpm for 12 h.

[0065] (2) Sample processing: Prepare sample pretreatment solution: Solution A (125mM NaOH, 1mM EDTA, 0.1% Tween 20); Solution B (250mM HCl, 10mM Tris-HCl). If the original material is a liquid culture sample, take 1mL and centrifuge at 10,000rpm for 1min, remove the supernatant, and rinse twice with saline; if it is a solid culture medium, directly pick a single colony and rinse with saline; add sample pretreatment solution A to the bacterial sample obtained above, lyse at 65℃ for 10min, then add sample pretreatment solution B, centrifuge at 10,000rpm for 5min, and the supernatant obtained is the sample DNA template.

[0066] (3) Results: The LAMP method of Example 2 was used to analyze 369 isolates to evaluate the diagnostic efficiency of the LAMP method. Figure 4 As shown. Compared with the results of LAMP detection by VITEK 2 microbial automatic identification instrument, the diagnostic sensitivity, diagnostic specificity and diagnostic accuracy are 99.09%, 100.00% and 99.46% respectively. The detection results of clinical strains show that the LAMP method of the present invention is a reliable and accurate method for detecting Staphylococcus aureus, and the detection specificity and sensitivity are both high.

[0067] In summary, the present invention provides a method for detecting Staphylococcus aureus based on loop-mediated isothermal amplification technology, and provides detection primers and a kit. The method of the present invention uses primers capable of amplifying the target gene DUF1361 domain-containing protein (GenBank accession number is CP038229.1) for amplification, and uses hydroxynaphthol blue color development to achieve rapid visual detection, with high specificity and sensitivity, accurate and reliable detection results, and has very good promotion and application value. SEQUENCE LISTING <110> Chengdu University of Traditional Chinese Medicine <120> Primer, kit and method for detecting Staphylococcus aureus <130> GY041-2021P0114235CCR4 <160> 5 <170> PatentIn version 3.5 <210> 1 <211> 618 <212> DNA <213> DUF1361 domain-containing protein <400> 1 atgcaatctc gatatatcgc tagaatttac tttttaattt tatttatcgt ctcccttttt 60 gagactaaaa tttttcaatt tatgacttta aatttgtttt tagcatatat accttttgag 120 cttagtctat tattacgatt attcaaaccg aataaaaagt atgaatggcc actctttatc 180 atatatagtt ttatatttgt gttatactttta ccaaatacat tttatatggt aactgattta 240 atccatttga accaatttca attcaacttt tacgcaggac taaatttaag tgagtggaaa 300 tactttacct atttactgct tggtgtcttc ttagcggttt atgtgatgat tttaatctat 360 tttgaaatac taacattgac ttctcaccgt tggcttaata gattaattgt tgtcgtgcta 420 atgtttttaa atggattcgg aatttatatt ggtcgtttct tacgcttaca ttccgttat 480 ttctttaatg agcccttaca tgttttaaat cacattctag aaagtctaac gcttaaaact 540 gctatgtttg tatgttttat ggttgtcatg caagcagcaa ttctattatt tggaaaagga 600 gtgcgtttga acaagtga 618 <210> 2 <211> 25 <212> DNA <213> F3 <400> 2 cgttggctta atagattaat tgttg 25 <210> 3 <211> 19 <212> DNA <213> B3 <400> 3 acgcactcct tttccaaat 19 <210> 4 <211> 48 <212> DNA <213> FIP <400> 4 acggaatgta agcgtaagaa acgcgtgcta atgtttttaa atggattc 48 <210> 5 <211> 44 <212> DNA <213> GDP <400> 5 agaaagtcta acgcttaaaa ctgctgaatt gctgcttgca tgac 44

Claims

1. A primer set for detecting Staphylococcus aureus, It is characterized in that It is a primer set capable of amplifying a specific base sequence of a target gene; the target gene is DUF1361 domain-containing protein, with a GenBank accession number of CP038229.1, and the specific base sequence is the base sequence of positions 704683-705300 of the target gene, as shown in SEQ ID NO.1; The primer set includes the following primers: External primer F3: the sequence is shown in SEQ ID NO.2; External primer B3: the sequence is shown in SEQ ID NO.3; Internal primer FIP: the sequence is shown in SEQ ID NO.4; Internal primer BIP: The sequence is shown in SEQ ID NO.

5.

2. A kit for detecting Staphylococcus aureus, It is characterized in that It comprises the primer set according to claim 1.

3. The kit according to claim 2, It is characterized in that It includes the following components in parts by volume: 10× buffer: 2.5 parts, 8.0 U / μL Bst 2.0 DNA polymerase: 1 part, 100 mM magnesium sulfate aqueous solution: 1.5 parts, 10 mM dNTP aqueous solution: 3 parts, 5 M betaine aqueous solution: 4 parts, 10 μM outer primer F3 aqueous solution: 0.5 parts, 10 μM outer primer B3 aqueous solution: 0.5 parts, 10 μM inner primer FIP aqueous solution: 4 parts, 10 μM inner primer BIP aqueous solution: 4 parts, water: 2 parts; The 10× buffer contains 200 mM Tris-HCl (pH 8.8), 500 mM potassium chloride, 100 mM ammonium sulfate, 20 mM magnesium sulfate, and 1% v / v Tween-20.

4. The kit according to claim 3, It is characterized in that The invention also includes a color developing agent, wherein the color developing agent is hydroxynaphthol blue, SYBR TM Green I, ethidium bromide, or calcein.

5. The kit according to claim 4, It is characterized in that The color developer is selected from hydroxynaphthol blue.

6. The kit according to claim 5, It is characterized in that The dosage of the hydroxynaphthol blue is: 1 volume portion of a 3 mM hydroxynaphthol blue aqueous solution.

7. The kit according to any one of claims 3 to 6, It is characterized in that The water is enzyme-free water.